Kazakhstan's first cancer drug is scheduled to hit the market in mid-2027.
The first domestic anti-cancer drug is planned to be launched on the Kazakhstan market in mid-2027. This was announced by the Minister of Science and Higher Education, Sayisat Norbek, in a briefing at the Central Communication Service.
The first phase of the clinical trials has been successfully completed, now scientists are starting the second. Drug development was delayed due to strict testing requirements.